BCWM
ABMD

Bartlett & Co Wealth Management’s Abiomed Inc ABMD Stock Holding History

Bartlett & Co Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-59
Closed -$14.5K – 1207
2022
Q3 		$14.5K Hold
59
– – ﹤0.01% 762
2022
Q2 		$14.6K Hold
59
– – ﹤0.01% 792
2022
Q1 		$19.5K Buy
+59
New +$18.2K ﹤0.01% 733
2020
Q4 		– Sell
-40
Closed -$11.1K – 1226
2020
Q3 		$11.1K Buy
+40
New +$11.5K ﹤0.01% 668

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bartlett & Co Wealth Management's ABMD Position: Q4 2022 in Review

Bartlett & Co Wealth Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 59 shares — an estimated $14.5K sold.

Bartlett & Co Wealth Management first reported a position in ABMD in Q3 2020 and held it in 4 quarters. The position peaked at $19.5K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Bartlett & Co Wealth Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 59 Abiomed Inc shares in Q4 2022, an estimated $14.5K.
  • Bartlett & Co Wealth Management first reported a position in Abiomed Inc in Q3 2020 and held it in 4 quarters.
  • Bartlett & Co Wealth Management's Abiomed Inc position peaked at $19.5K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Bartlett & Co Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2024.